colleagues performed a meta-analysis of relevant guided tissue regeneration (GTR) articles over the previous 20 years (1). The purpose of the present research was to expand on that work, particularly searching for trends discriminating between bioabsorbable and nonbioabsorbable barriers, as well as the use of enamel matrix derivative, with respect to interproximal bony defects. The most recent periodontal journals were reviewed and a search of PubMed (National Institutes of Health) was conducted via the internet covering 1990 to the present. Forty-nine articles were found to be relevant and within established parameters. The data were analyzed using (a) a variation of the methods described in Laurell et al. 
Introduction
Guided tissue regeneration (GTR) is defined as: "… procedures attempting to regenerate lost periodontal structures through differential tissue responses. Barrier techniques, using materials such as expanded polytetrafluoroethylene (ePTFE), polyglactin, polylactic acid, calcium sulfate, and collagen, are employed in the hope of excluding epithelium and the gingival corium from the root in the belief that they interfere with regeneration." (2) . During the 1980's and 1990's, a large volume of investigation into guided tissue regeneration (GTR) using membranes established its effectiveness in treating the specific periodontitis-induced resorptive defects, particularly vis-à-vis other surgical and non-surgical modalities. In a 1998 review article, Laurell and colleagues performed a meta-analysis of articles over the previous 20 years, comparing the outcomes from (a) open flap, versus (b) open flap plus bone grafts, versus (c) GTR in "intrabony" defects (1) . In their final analysis, Laurell and colleagues combined the results from all GTR articles, and found that the average CAL gain was 4.2 mm, and that there were no significant differences in the outcomes between bioabsorbable and non-bioabsorbable membranes. Greenstein and Lamster included Laurell and colleagues' results, and compared them to representative results of other therapies, including scaling and root planing, controlled release antibiotic fibers, and enamel matrix protein, with the conclusion that GTR produced the overall best result, according to their criteria (3) .
The next generation of strategies for regeneration was enamel matrix derivative (EMD). EMD has been found to exhibit periodontal regeneration properties, specifically associated with amelogenin (4) . EMD is viewed as the third generation of periodontal regeneration methods, having been preceded by bone replacement grafts and GTR. In a 2002 review article, Kalpidis and Ruben performed a meta-analysis of articles of clinical trials over the previous 5 years, comparing the outcomes from (a) open flap debridement (OFD) (Clinical Attachment Gain [CAL gain] of 2.1 ± 0.7 mm), versus (b) GTR (CAL gain of 3.8 ± 0.8 mm), versus (c) EMD guided bone regeneration (EGR) (CAL gain of 3.2 ± 0.9 mm) in "intrabony" defects (5) . A number of years have elapsed since the Laurell et al. (1) and Kalpidis and Ruben (5) articles, and more research has been accomplished regarding the outcomes of regeneration.
The purpose of this investigation was to expand on the work of Laurell et al. (1) and Kalpidis and Ruben, (5) particularly searching for trends discriminating between bioabsorbable and non-bioabsorbable barriers, and different types of bioabasorbable barriers, as well as EMD, with respect to interproximal intrabony defects resulting from periodontitis.
Materials and Methods
In order to confirm that GTR leads to more CAL gain than open flap debridement (OFD) in interproximal, infrabony periodontal defects, Laurell et al. was used to identify 11 usable articles which had investigated OFD alone, without citric acid, and 11 usable articles which had investigated OFD with bone grafting, and without citric acid (1) . Five new articles available since 1998 were added to that set of "OFD alone", while one new article on OFD with bone grafting was added to that set of "OFD with bone grafting".
For articles covering GTR during the 1990's and the first five years of this decade, a search of PubMed (National Institutes of Health) was conducted via the internet. The following parameters were used: Only those articles investigating regeneration of periodontal bone in infrabony / intrabony defects were processed. In analyzing the success of GTR and EMD, only those articles which featured the following data were used: (a) Number of Defects; (b) Initial Probing Depth; (c) Residual Probing Depth; and (d) Clinical Attachment Level Gain. Defect Depth and Bone Gain were recorded where published in the respective articles. In considering synthetic barriers, we selected for analysis only those commercial barriers which are currently available in the United States, and have been accepted for use in guided tissue regeneration by the United States Federal Drug Administration. Given these constraints, 49 articles on guided tissue regeneration and enamel matrix derivative were found to be relevant.
Following the method of Laurell and colleagues, we weighted the power of each study "… according to the number of defects treated." (1) .That is, the number of defects treated (n) was multiplied by the mean that was derived for each category of data from the respective articles, such as CAL gain. The resulting values from this multiplication were summed for the specific category from all relevant articles, and that sum then divided by the total number of defects (N = n 1 + n 2 + …) in the respective category across all the relevant articles that were used in each analysis. The data were then analyzed using two levels of analysis. The first sought statistically significant comparisons of the data, and that will be discussed in the Results and in the Discussion. The second level of analysis was a simplistic meta-analysis method which compared the effectiveness of each barrier and which followed the method described in Laurell et al. (1) 
Results
The data is categorized according to groupings, each group corresponding to the research articles listed in a table. Two approaches were used in analyzing the data. Section I consists of three parts, each answering a question using statistical analyses. The three questions are: (a) Is there a significant correlation between Initial Probing Depth (IPD) and CAL gain for each grouping? (b) Is there a significant CAL gain for each grouping? And, (c) is there any significant difference between the groups, and is there any significant difference when combining Groups 1 and 2 (OFD), versus Groups 3 and 4 (ePTFE), versus Groups 5 through 7 (all bioabsorbable barriers), versus Group 8 (EMD by itself), versus Group 9 (EMD with graft and/or barrier), and versus Groups 3 through 9 (combination of all GTR and EMD).
Section II reflects a "simplistic data analysis" of each group, in that simple comparisons of averages for initial probing depth (IPD) and CAL gain were derived, with normalization to the IPD of open flap debridement (OFD) without graft material. Normalization was accomplished in order to eliminate the influence of varying IPDs, since we found that there is a correlation between IPD and CAL gain.
Section I. Statistical Data Analyses
The data analysis of this section of the study consists of three parts:
Correlation between Initial probing Depth and Cal Gain in each category.
The significance of the Cal Gain in each category. Analysis of variance of Cal Gain between categories.
Since there were only two articles listed in Table 10 , there is no comparison of Plasma Rich Protein in the following analyses. Only the groupings from Tables 1 through 9 are   Table 1 Open flap debridement alone without grafts analyzed and compared.
Part A Correlation
The correlations between Initial Probing Depth (IPD) and CAL Gain in each of the nine (9) categories of reviewed studies were first calculated with simple linear correlation (Pearson's correlation coefficient r). The results are summarized in the following table [(**) indicates significance at the 0.01 level (P < 0.01) and (*) indicates significance at the 0.05 level (P < 0.05)]:
The correlations between IPD and CAL Gain are significant at the .01 or .05 level in six of the nine categories in which the number of studies are ten or more. In case one may question the validity of using this parametric procedure, a non-parametric method, the Spearman's Rho, was also conducted and the results summarized in the following table:
The results of the rank-correlation are similar to the Pearson's r correlation with one more category (#6) showing a significant relationship. 
Part B CAL-Gain Statistics
The results presented in the following table clearly show that the CAL-Gain levels in all of the nine categories are highly significant. The reported sample sizes in the studies included in each grouping varied greatly. However, due to the different criteria used in choosing subjects Table 3 Guided tissue regeneration using non-bioabsorbable barriers without graft material among studies, for our statistical analysis we have decided not to "weight" each study by its sample size but rather treat each study as "equal".
Part C ANOVA
An attempt was made to compare the CAL-Gain in the nine categories, using the guideline of meta-analysis recommended by Hedges and Olkin (1985) (73) . The initial analysis of variance shows that the difference among the nine categories on CAL-Gain is highly significant as shown in the following ANOVA table. Table 4 Guided tissue regeneration using non-bioabsorbable barriers with graft material Table 5 Guided tissue regeneration using collagen bioabsorbable barriers without graft material A Tukey post-hoc comparisons showed the following pair-wise results: Y indicates significant difference on CAL-Gain between categories with P-value less than or equal to 0.05.
N indicates non-significant difference on CAL-Gain between categories with P-value greater than 0.05.
A selected numbers of contrasts were analyzed by using Scheffe's comparisons. The selection was based on the similar characteristics of the categories which were divided into six groups: (Categories 1 and 2), (Categories 3 and 4), (Categories 5 to 7), (Category 8), (Category 9), and (Categories 3 to 9). The results of comparisons among these groups are summarized in the following table:
Y indicates significant difference on CAL-Gain between groups with of P-value less than or equal to 0.05. N indicates non-significant difference on CAL-Gain between groups with P-value greater than 0.05.
Section II. Simplistic Data Analysis Open Flap Debridement
Analysis was accomplished in order to reconfirm Laurell et al. (1) and to establish a reference relationship between IPD and CAL gain. Tables 1 and 2 list the articles and data used in analyzing OFD outcomes for interproximal infrabony defects. Table 1 , the average mean CAL gain for interproximal defects using OFD alone was 1.81 mm, with a range of 0.4 mm to 2.5 mm. The corresponding average IPD was 7.19 mm.
Group 2: Open Flap Debridement, With Graft Material
From Table 2 , the average mean CAL gain for interproximal defects using OFD with graft material was 2.02 mm, with a range of 1.2 mm to 2.9 mm. The corresponding average IPD was 6.89 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of OFD with graft material would be 2.10 mm. Table 4 , analysis of research using nonbioabsorbable barriers with graft material for interproximal defects resulted in the average mean CAL gain of 2.60 mm, with a range of 1.7 mm to 3.8 mm. The corresponding average IPD was 7.71 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of ePTFE with graft material would be 2.60 mm. Table 7 Polylactic acid derivatives without graft material Table 8 Regeneration using enamel matrix derivative (EMD); no grafts, no barriers
Guided Tissue Regeneration

Bioabsorbable Barriers
Group 5: Collagen without Grafts Using Table 5 , analysis of research using collagen barriers without graft material for interproximal defects resulted in the average mean CAL gain of 2.44 mm, with a range of 2.0 mm to 2.58 mm. The corresponding average IPD was 6.93 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of collagen without graft material would be 2.53 mm.
Group 6: Collagen with Grafts
Using Table 6 , analysis of research using collagen barriers with graft material for interproximal defects resulted in the average mean CAL gain of 3.48 mm, with a range of 2.3 mm to 4.1 mm. The corresponding average IPD was 7.87 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of collagen with graft material would be 3.18 mm.
Group 7: Polylactic Acid Derivatives without Grafts
Using Table 7 , analysis of research using polylactic acid (PLA) barriers without graft material for interproximal defects resulted in an average mean CAL gain of 3.15 mm, with a range of 2.0 mm to 4.6 mm. The corresponding average IPD was 7.70 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of PLA without graft material would be 2.94 mm.
Biologically Active Materials
Group 8: Enamel Matrix Derivative Guided Bone Regeneration
Using Table 8 , analysis of research using enamel matrix derivative (EMD) without graft material or membranes, resulted in an average mean CAL gain of 3.71 mm, with a range of 1.58 mm to 6.45 mm. The corresponding average IPD was 8.38 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of EMD by itself would be 3.18 mm. Table 9 Regeneration using enamel matrix derivative (EMD) plus barrier and/or graft Group 9: Enamel Matrix Derivative with Graft Material and/or Barriers Using Table 9 , analysis of research using EMD with graft material and/or membranes, resulted in an average mean CAL gain of 3.89 mm, with a range of 3.0 mm to 5.8 mm. The corresponding average IPD was 8.23 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of EMD with graft material and/or membranes would be 3.40 mm.
The comparisons of these average CAL gains are shown in Fig. 1 and 2 .
Platelet Rich Plasma
Using Table 10 , analysis of research using Platelet Rich Plasma (PRP) and graft material (two articles), resulted in an average mean CAL gain of 3.67 mm, with a range of 3.4 mm to 4.12 mm. The corresponding average IPD was 7.74 mm. When normalized to the average IPD of OFD (7.19 mm), the CAL gain of PRP with graft material would be 3.58 mm.
Discussion
In-Depth Statistical Data Analysis
Consistently, a correlation between the IPD and CAL gain was found for each surgical approach. In most cases, the correlation was statistically significant (P < 0.05), both by using the Pearson's r correlation and the Spearman's Rho. The only correlations which were not found to be significant were those where a low number of articles existed, and therefore weakened the statistical analysis. We attempted to fit the data into non-linear equations, but found that linear correlations between IPD and CAL gain gave the best "fit" in comparing the groupings.
The CAL gains from each grouping (ranging from 1.77 mm to 3.88 mm) are highly significant, implying that one could reliably anticipate the corresponding amount of CAL gain from whatever surgical method and barrier or biologically active molecule is utilized.
In comparing the CAL gains from each grouping, the ANOVA reveals significant differences in outcomes between (a) non-bioabsorbable membranes without grafts Table 10 Regeneration using platelet rich plasma (PRP) Fig. 1 In order to eliminate differences due solely to a variation in initial probing depth, all other CAL gains were normalized to the IPD of OFD without grafts (7.19 mm).
The bar graphs indicate a trend towards more CAL gain when using barriers in GTR, versus OFD. It is possible that the lack of statistical significance when comparing non-bioabsorbable barriers with graft material to OFD with or without graft material, may be due to the low number of studies (six) using non-bioabsorbable barriers with graft material. Similarly, the same may be true of collagen without graft material compared to OFD with or without graft material, in that only four sets of data were found which used collagen without graft material. However, the mean CAL gains for all groups were found to be highly significant. Therefore it is possible that even with more research, the same ANOVA outcome will prevail. Considering another unexpected outcome, it is also possible that polylactic acid derivatives without grafts may be statistically superior to OFD with grafts if the newer generation of polylactic acid barriers is used. Clearly, by this analysis, (a) non-bioabsorbable membranes without grafts, (b) collagen with grafts, and (c) any combination of EMD with or without barriers are all superior to OFD with or without grafts, and (d) polylactic acid without grafts is superior to OFD without grafts.
Statistical versus Clinical Significance
Often there is a question whether a comparison that is found to be statistically significant is actually clinically significant (75) . As a guide, we would like to suggest that if a comparison is found to be statistically significant and the difference between the two numbers being compared is greater than the standard error of measurement for whatever device is being used, then the difference may be considered clinically significant too. For example, if the standard error of measurement for probing with an automated probe used in a study is found to be 1.0 mm, then any difference less than 1 mm, however statistically significant, would not be considered clinically significant.
Simplistic Data Analysis
Relationships of the Initial Probing Depths to the CAL gains
Several researchers have reported a correlation between IPD and CAL gain (1, 41, 76) . Laurell et al performed a correlation analysis on articles which presented individual data for each subject within the research population (1). They found that both CAL gain and bone fill correlated significantly with defect depth, R = 0.52 and 0.53. Some of the studies which we investigated did not include "defect depth," but all did include initial probing depth (IPD), and that was used in our analyses. Since there appears to be a direct relationship between IPD and OFD, one would expect that if a study used IPDs of greater depth, then the outcomes would yield greater CAL gains. That is what we found when we did a separate analysis on data from GTR studies using titanium-backed ePTFE membranes. Initially it appeared that titanium-backed membranes yielded significantly more CAL gain. However, the researchers involved in those articles were using the titanium backed ePTFE for IPDs that were deeper than other groups, so if the data were normalized to a standard IPD, that CAL gain was more in line with CAL gains derived from other barrier membranes at a standard IPD. Therefore, in our trend comparison below, we normalized all average CAL gains to the IPD of OFD without grafts in order to compare the effectiveness of the different membranes and biologically active molecules.
Trend Comparison of the Different Membranes and Biologically Active Products, with and without Graft Material
Using our data, Fig. 1 of CAL gains from the different surgical approaches illustrates that OFD resulted in far less CAL gain when compared to (a) non-bioabsorbable membranes in general and to (b) bioabsorbable membranes in general. Therefore, regarding OFD versus GTR, our findings support what others have found. Figure 1 also indicates that the outcomes from using non-bioabsorbable and bioabsorbable membranes are similar, except for a slight decrease in CAL gain when using non-bioabsorbables with grafts and when using collagen without graft material. Figure 2 illustrates that EMD without grafts has an average outcome similar to that of non-bioabsorbable membranes in general, and to a lesser degree, bioabsorbable membranes in general. On the other hand, EMD with grafts and / or membranes produced an average CAL gain about 7% higher than EMD without grafts and / or membranes, and non-bioabsorbable membranes.
Bone Grafting. When considering GTR with membranes, the use of bone graft as an adjunct to e-PTFE does not appear to enhance the CAL gain (2.60 mm, normalized versus 3.34 mm, normalized). On the other hand, adding bone grafting to collagen membranes does appear to enhance the CAL gain vis-à-vis OFD.
Collagen versus Polylactic Acid. The analysis of pertinent articles revealed that the use of polylactic acid barriers tended to result in about the same CAL gain. The data for the two groups was not significantly different by the ANOVA process.
Use of Antibiotics. Two of the articles include the use of antibiotics with non-bioabsorbables.(36,37) However, the variables between the investigations are so extreme that no overall trend or conclusion about the use of antibiotics can be made authoritatively. Zucchelli and colleagues compared topical metronidazole with systemic amoxicillin, finding a CAL gain or 4.8 mm in the former, and 5.3 mm in the latter (37) . Yoshinari et al. compared 2% minocycline ointment using e-PTFE versus no ointment, and found that the antibiotic usage was associated with about 1.0 mm more CAL (36). When combining data from the two articles, we found an average CAL gain of 4.52 mm.
Unusual Barriers. Our literature search found only one article which investigated bioactive glass, which appears to have wound healing which is significantly different from barrier membranes (78) . In that article, for those initial probing depths equal to or less than 7 mm, the CAL gain was 2.2 ± 0.77 mm, which is less than the averages that we found for non-bioabsorbable membranes in general (3.17 mm) and bioabsorbable membranes (2.83 mm). However, Park and colleagues did report much greater CAL gain (4.0 ± 1.3 mm) with deeper probing depths (> 7 mm) (78) .
Comparison with other Meta-Analyses of Regeneration Research. When comparing OFD with GTR, the outcomes for OFD (increases in CAL of 1.81 mm without graft material, and 2.10 mm with graft material) were less than those for GTR, whether using nonbioabsorbable or bioabsorbable barriers, with or without graft material (Fig. 1) . These relative outcomes are consistent with Laurell et al. (1) . When analyzing the set of data for all membranes in their respective categories, the average CAL gain when treating interproximal / infrabony defects was approximately 3.17 mm when considering non-bioabsorbable barriers with and without graft material (combining Tables 3 and 4) , and 2.96 mm when considering all bioabsorbable barriers with and without graft material (combining Tables 5, 6 , and 7). These results fall somewhat short of the 4.2 mm found by Laurell and colleagues when considering all membranes, both non-bioabsorbable and bioabsorbable, and not distinguishing whether or not graft material was used (1). Laurel and colleagues included research from 3 articles which utilized a specific bioabsorbable, polylactic acid membrane (Guidor AB, Huddinge, Sweden) which was available, but is not currently marketed in the United States. These 3 articles all reported CAL gains well above 4.0 mm, which therefore shifted their mean CAL gain higher. Otherwise, Laurell and colleagues would have reported a mean CAL gain relatively similar to our data.
In an elaborate statistical meta-analysis, Needleman et al. found that "… for GTR the weighted mean difference between test and control was 1.11 mm, …" and for "GTR + bone substitutes 1.25 mm," which is also consistent with our findings (77) . However, Needleman and colleagues grouped all non-bioabsorbable and bioabsorbable membranes together in their analysis. Their article does point out the major limitation of meta-analysis studies of GTR; that is, a "marked variability between studies." (77) . In reviewing the source articles, there appears to be a chronological trend towards standardizing the studies to the extent, for instance, that in more recent articles the number of walls of the bony defects are specified, and subjects who smoke are now being excluded from the studies.
In a 2003 systematic review, Murphy and Gunsolley found that "… GTR was favored over open flap debridement (OFD) therapies (P < 0.0001)." (79) . Unlike our results, Murphy and Gunsolley found no differences "… among barrier types, but barrier types could explain some heterogeneity in the results." The authors analyzed articles in two main categories: Intrabony defects and Furcation defects. We only analyzed articles which dealt with Intrabony defects. For Murphy and Gunsolley, the total number of studies for the Intrabony defects category was 44. Their exclusion criteria are valid and their further evaluation of the methodologies revealed what we found regarding lack of standardization, ranging from the patients smoking to the length of the studies. Their study reflects a higher degree of evidence-based processing of the different articles compared to our inclusion/exclusion criteria. Thus, we identified and used 49 articles. On the other hand, Murphy and Gunsolley did not take into account the effect of the IPD on the final outcome; that is, they did not accomplish a normalization of the CAL gain, so that those studies with inherently deeper IPDs are not adjusted for the fact that a deeper IPD will provide a greater amount of CAL gain. We accomplished that normalization under the Simplistic Data Analysis above, and have those outcomes in Figs. 1 and 2 . Muphey and Gunsolley did not find differences between barrier types. We did find differences between barrier types and whether grafts were or were not used.
Limitations. The meta-analysis procedures used in this work have inherent limitations. (a) Raw data was not available, therefore an overall standard deviation derived from the raw data was impossible to calculate. (b) Since each article involved a unique research protocol, there are bound to be at least subtle differences in population inclusion criteria. For instance, some articles allowed smokers, others did not. (c) Finally, with the CAL gains dependent on the IPD, statistics involving correlations derived from raw data, and leading to the ability to compare to a specific reference IPD, are required for meaningful comparisons between barriers.
Conclusion. Non-bioabsorbable membranes without graft material, collagen membranes with graft material, and EMD with or without graft material were all found to be superior to OFD with or without graft material. In addition, polylactic acid derivatives without grafts were found to be superior to OFD without grafts, and non-bioabsorbables without graft material were found to be superior to collagen without graft material. Based on the lack of significant differences mentioned above, it would be rational to conduct 3 split-mouth prospective research studies in order to confirm: (a) whether the CAL gain using nonbioabsorbable barriers with graft material is or is not statistically different from OFD with or without graft material; (b) whether the CAL gain using collagen without graft material is or is not statistically different from OFD with or without graft material; and (c) whether the CAL gain using the newer generation of polylactic acid is or is not statistically different from OFD with graft material. The following constraints are suggested: (a) Intrabony defects which are as identical as possible; (b) Patients who are healthy and do not smoke; and (c) Standardization of the use of antibiotics and root preparation. Also, in accordance with Greenstein and Lamster, a power analysis, a sample size determination, and a definition of a clinically relevant threshold for CAL gain should be established prior to commencement of the study (75 
